清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Biomarkers for staging fibrosis and non-alcoholic steatohepatitis in non-alcoholic fatty liver disease (the LITMUS project): a comparative diagnostic accuracy study

医学 脂肪性肝炎 肝活检 脂肪肝 内科学 胃肠病学 纤维化 活检 石蕊 病理 疾病 物理化学 化学
作者
Yasaman Vali,Jenny Lee,Jérôme Boursier,Salvatore Petta,Kristy Wonders,Dina Tiniakos,Pierre Bédossa,Andreas Geier,Sven Francque,Mike Allison,George Papatheodoridis,Helena Cortêz-Pinto,Raluca Pais,Jean‐François Dufour,Diana Julie Leeming,Stephen A. Harrison,Yu Chen,Jeremy Cobbold,Michael Pavlides,Adriaan G. Holleboom,Hannele Yki‐Järvinen,Javier Crespo,M.A. Karsdal,Rachel Ostroff,Mohammad Hadi Zafarmand,Richard Torstenson,Kevin L. Duffin,Carla Yunis,Clifford A. Brass,Mattias Ekstedt,Guruprasad P. Aithal,Jörn M. Schattenberg,Elisabetta Bugianesi,Manuel Romero‐Gómez,Vlad Ratziu,Quentin M. Anstee,Patrick M. Bossuyt
出处
期刊:The Lancet Gastroenterology & Hepatology [Elsevier]
卷期号:8 (8): 714-725 被引量:84
标识
DOI:10.1016/s2468-1253(23)00017-1
摘要

Background The reference standard for detecting non-alcoholic steatohepatitis (NASH) and staging fibrosis-liver biopsy-is invasive and resource intensive.Non-invasive biomarkers are urgently needed, but few studies have compared these biomarkers in a single cohort.As part of the Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS) project, we aimed to evaluate the diagnostic accuracy of 17 biomarkers and multimarker scores in detecting NASH and clinically significant fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) and identify their optimal cutoffs as screening tests in clinical trial recruitment.Methods This was a comparative diagnostic accuracy study in people with biopsy-confirmed NAFLD from 13 countries across Europe, recruited between Jan 6, 2010, and Dec 29, 2017, from the LITMUS metacohort of the prospective European NAFLD Registry.Adults (aged ≥18 years) with paired liver biopsy and serum samples were eligible; those with excessive alcohol consumption or evidence of other chronic liver diseases were excluded.The diagnostic accuracy of the biomarkers was expressed as the area under the receiver operating characteristic curve (AUC) with liver histology as the reference standard and compared with the Fibrosis-4 index for liver fibrosis (FIB-4) in the same subgroup.Target conditions were the presence of NASH with clinically significant fibrosis (ie, at-risk NASH; NAFLD Activity Score ≥4 and F≥2) or the presence of advanced fibrosis (F≥3), analysed in all participants with complete data.We identified thres holds for each biomarker for reducing the number of biopsybased screen failures when recruiting people with both NASH and clinically significant fibrosis for future trials.Findings Of 1430 participants with NAFLD in the LITMUS metacohort with serum samples, 966 (403 women and 563 men) were included after all exclusion criteria had been applied.335 (35%) of 966 participants had biopsy-confirmed NASH and clinically significant fibrosis and 271 (28%) had advanced fibrosis.For people with NASH and clinically significant fibrosis, no single biomarker or multimarker score significantly reached the predefined AUC 0•80 acceptability threshold (AUCs ranging from 0•61 [95% CI 0•54-0•67] for FibroScan controlled attenuation parameter to 0•81 [0•75-0•86] for SomaSignal), with accuracy mostly similar to FIB-4.Regarding detection of advanced fibrosis, SomaSignal (AUC 0•90 [95% CI 0•86-0•94]), ADAPT (0•85 [0•81-0•89]), and FibroScan liver stiffness measurement (0•83 [0•80-0•86]) reached acceptable accuracy.With 11 of 17 markers, histological screen failure rates could be reduced to 33% in trials if only people who were marker positive had a biopsy for evaluating eligibility.The best screening performance for NASH and clinically significant fibrosis was observed for SomaSignal (number needed to test [NNT] to find one true positive was four [95% CI 4-5]), then ADAPT (six [5-7]), MACK-3 (seven [6-8]), and PRO-C3 (nine [7-11]).Interpretation None of the single markers or multimarker scores achieved the predefined acceptable AUC for replacing biopsy in detecting people with both NASH and clinically significant fibrosis.However, several biomarkers could be applied in a prescreening strategy in clinical trial recruitment.The performance of promising markers will be further evaluated in the ongoing prospective LITMUS study cohort.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ikun0000完成签到,获得积分10
5秒前
午后狂睡完成签到 ,获得积分10
21秒前
emxzemxz完成签到 ,获得积分10
21秒前
yellowonion完成签到 ,获得积分10
21秒前
岁月如歌完成签到,获得积分0
38秒前
英俊的铭应助过眼云烟采纳,获得10
40秒前
重重重飞完成签到 ,获得积分10
48秒前
theo完成签到 ,获得积分10
50秒前
allrubbish完成签到,获得积分10
58秒前
凤兮完成签到 ,获得积分10
59秒前
1分钟前
过眼云烟发布了新的文献求助10
1分钟前
之_ZH完成签到 ,获得积分10
1分钟前
淡淡菠萝完成签到 ,获得积分10
1分钟前
大饼完成签到 ,获得积分10
1分钟前
1分钟前
酷酷的紫南完成签到 ,获得积分10
1分钟前
Ggap1发布了新的文献求助10
1分钟前
你的笑慌乱了我的骄傲完成签到 ,获得积分10
1分钟前
应夏山完成签到 ,获得积分10
1分钟前
JasonTrue完成签到,获得积分10
1分钟前
芒芒发paper完成签到 ,获得积分10
1分钟前
高高高完成签到 ,获得积分10
1分钟前
过眼云烟完成签到,获得积分10
1分钟前
小乙猪完成签到 ,获得积分0
1分钟前
大气的尔蓝完成签到,获得积分10
1分钟前
孤独剑完成签到 ,获得积分10
2分钟前
北国雪未消完成签到 ,获得积分10
2分钟前
LELE完成签到 ,获得积分10
2分钟前
快乐含烟完成签到 ,获得积分10
2分钟前
丹妮完成签到 ,获得积分10
2分钟前
HuiHui完成签到,获得积分10
2分钟前
仁者无惧完成签到 ,获得积分10
2分钟前
imica完成签到 ,获得积分10
2分钟前
醉熏的千柳完成签到 ,获得积分10
2分钟前
双眼皮跳蚤完成签到,获得积分10
2分钟前
坦率的从波完成签到 ,获得积分10
2分钟前
jtyt完成签到,获得积分10
3分钟前
sponge完成签到 ,获得积分10
3分钟前
wushuimei完成签到 ,获得积分10
3分钟前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
Immigrant Incorporation in East Asian Democracies 600
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3968532
求助须知:如何正确求助?哪些是违规求助? 3513358
关于积分的说明 11167309
捐赠科研通 3248700
什么是DOI,文献DOI怎么找? 1794453
邀请新用户注册赠送积分活动 875030
科研通“疑难数据库(出版商)”最低求助积分说明 804664